絞り込み

16646

広告

手塚治虫さん トキワ荘の天井板に描いた直筆画 豊島区に寄贈 (NHK)

マンガの神様、手塚治虫さんが若き日を過ごしたアパート「トキワ荘」の天井板に描いた貴重な直筆画が東京 豊島区に寄贈されました。来月オープンする「トキワ荘」を復元し...

  1. 女川2号機 審査「合格」…21年度以降の...
  2. 東北電力 女川原発2号機 地元自治体が再...
  3. 無観客ライブを無料配信 会場費などはファ...
  4. 突然の異常行動を伴う頭痛、疑うべき疾患は...

ニュース一覧

Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention.

著者 Paciaroni M , Agnelli G , Caso V , Silvestrelli G , Seiffge DJ , Engelter S , De Marchis GM , Polymeris A , Zedde ML , Yaghi S , Michel P , Eskandari A , Antonenko K , Sohn SI , Cappellari M , Tassinari T , Tassi R , Masotti L , Katsanos AH , Giannopoulos
Stroke.2019 Jun 25 ; ():STROKEAHA119025350.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (96view , 0users)

Full Text Sources

Miscellaneous

Background and Purpose- Despite treatment with oral anticoagulants, patients with nonvalvular atrial fibrillation (AF) may experience ischemic cerebrovascular events. The aims of this case-control study in patients with AF were to identify the pathogenesis of and the risk factors for cerebrovascular ischemic events occurring during non-vitamin K antagonist oral anticoagulants (NOACs) therapy for stroke prevention. Methods- Cases were consecutive patients with AF who had acute cerebrovascular ischemic events during NOAC treatment. Controls were consecutive patients with AF who did not have cerebrovascular events during NOACs treatment. Results- Overall, 713 cases (641 ischemic strokes and 72 transient ischemic attacks; median age, 80.0 years; interquartile range, 12; median National Institutes of Health Stroke Scale on admission, 6.0; interquartile range, 10) and 700 controls (median age, 72.0 years; interquartile range, 8) were included in the study. Recurrent stroke was classified as cardioembolic in 455 cases (63.9%) according to the A-S-C-O-D (A, atherosclerosis; S, small vessel disease; C, cardiac pathology; O, other causes; D, dissection) classification. On multivariable analysis, off-label low dose of NOACs (odds ratio [OR], 3.18; 95% CI, 1.95-5.85), atrial enlargement (OR, 6.64; 95% CI, 4.63-9.52), hyperlipidemia (OR, 2.40; 95% CI, 1.83-3.16), and CHADS-VASc score (OR, 1.72 for each point increase; 95% CI, 1.58-1.88) were associated with ischemic events. Among the CHADS-VASc components, age was older and presence of diabetes mellitus, congestive heart failure, and history of stroke or transient ischemic attack more common in patients who had acute cerebrovascular ischemic events. Paroxysmal AF was inversely associated with ischemic events (OR, 0.45; 95% CI, 0.33-0.61). Conclusions- In patients with AF treated with NOACs who had a cerebrovascular event, mostly but not exclusively of cardioembolic pathogenesis, off-label low dose, atrial enlargement, hyperlipidemia, and high CHADS-VASc score were associated with increased risk of cerebrovascular events.
PMID: 31234756 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード